A Plastic Surgery Group out of Albany, along with several of its staff, have been charged following guilty pleas that they were using non FDA approved Botox products on their patients.
The Plastic Surgery Group, LLP (TPSG), of Albany has been sentenced and ordered to pay restitution in the amount of $106,686, and a fine of $200,000, in connection with TPSG’s plea of guilty to one felony count of misbranding drugs.
The company was sentenced in Federal District Court in Albany, along with Doctors William F. DeLuca Jr., Douglas M. Hargrave, Jeffrey L. Rockmore, Steven M. Lynch, and John D. Noonan, who were all sentenced to probation with community service and ordered to pay restitution in the amount of $106,686 and a fine of $5,000.
TPSG’s practice administrator, Peter M. Slattery, and supervisory nurse Susan F. Knott were also sentenced and ordered to pay
restitution in the amount of $106,686, and fines in the amount of $1,000 and $500, respectively.
All the individuals were sentenced in connection with their guilty pleas to one misdemeanor count of misbranding drugs.
According to plea agreements, starting in approximately February 2004 and continuing to December 2004, defendant TPSG ceased using the FDA-approved Botox and Botox Cosmetic and began exclusively using a non-FDA approved TRI-toxin on its patients seeking treatments with Botulinum Toxin Type A for facial wrinkles.
Five physicians, whose professional corporations were partners of TPSG (the “treating physicians”), with the assistance of TPSG nurses, injected approximately 150 patients with the unapproved product.
Related Botox Patient posts: Bad BotoxWholesale Dysport from Medical Spa RXBotox Mistakes You Should AvoidWholesale BotoxBotox from Canada
